← All Chemours CO filings

Chemours CO 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
CC
Chemours CO
10-K: Chemours Reports 2025 Net Loss, Navigates PFAS Litigation
The Chemours Company reported a significant net loss in 2025, driven by substantial litigation charges and operational challenges in its Titanium Technologies and Advanced Performance Materials segments, despite growth in Thermal & Specialized Solutions.
NYSE
CC
Chemours CO
10-K: Chemours Releases 10-K Filing: Details Strategy, Performance, and Risks
Chemours' 10-K filing highlights its 'Pathway to Thrive' strategy, segment performance, and key risk factors for the fiscal year ended December 31, 2024.
NYSE
CC
Chemours CO
10-K: Chemours Extends Employment of Special Litigation Counsel, Modifies Compensation
Chemours has amended its agreement with David C. Shelton, extending his employment as Special Litigation Counsel by one year to December 31, 2024, and adjusting his compensation and benefits accordingly.